crypto with good future Top Knowledge

The annual evaluation report of the big model in the financial field was released, and the big model of Step Star/Fortune Leap Star performed well. The 6th Shanghai International Forum on Financial Technology was held in Shanghai. At the meeting, Shanghai Artificial Intelligence Laboratory, together with Shanghai University of Finance and Economics and Shanghai Cooper Technology Co., Ltd., released the Report on Evaluation of Large Models in Financial Field (2024), which comprehensively evaluated 20 models from five dimensions: model basic ability, financial security and value alignment ability, financial risk control ability, financial professional cognitive ability and financial business auxiliary expansion ability. The comprehensive scores of Anthropic, Step Star/Fortune Star and Alibaba ranked in the top three. Step-2-16k model of Step Star/Fortune Star got the second comprehensive score, and the multi-modal comprehensive score of Finstep model got the first.Tesla China will launch advanced intelligent summoning ASS function for vehicles with EAP or FSD. On December 13th, Tesla China official website launched a brand-new vehicle function-Actually Smart Summon. This function is suitable for Tesla vehicles with EAP (enhanced automatic driving assistance function) or FSD (full automatic driving capability). Tesla owners can automatically park the vehicle from the parking space and drive to the owner's side or the location designated by the owner on the mobile phone by operating on the Tesla application of the mobile phone, and the vehicle needs to be kept within the owner's sight during the moving process. It is reported that this function will be pushed to the owner through OTA remote software update function.Li Dongsheng said that low-price competition has no way out, and it will only get involved. On December 11th, at TCL Global Innovation Conference, founder Li Dongsheng said that in the current market competition, low-price competition has no way out, and it will only get involved in endless "involution". To surpass its competitors, it is necessary to strive for more breakthroughs in high-end products. He Jun, vice president of TCL Industry, talked about the current development of industrial software enterprises in China in a subsequent interview. He also said that from the aspects of financing environment and market support for enterprises, China is not an environment where good software enterprises can be born at present, but in the long run, industrial software may make a breakthrough in China software, and this time will not be very fast, and it will not be seen for three or five years.

Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.The Ministry of Industry and Information Technology decided to set up the Ministry of Artificial Intelligence Standardization Technical Committee, and the Ministry of Industry and Information Technology decided to set up the Ministry of Artificial Intelligence Standardization Technical Committee, numbered MIIT/TC1, which is mainly responsible for the compilation and revision of industry standards in the fields of artificial intelligence evaluation and testing, operation and maintenance, data set, basic hardware, software platform, large model, application maturity, application development management and artificial intelligence risk. The first Technical Committee of Artificial Intelligence Standardization of the Ministry of Industry and Information Technology consists of 41 members, and the secretariat is undertaken by China Information and Communication Research Institute.The 30-year main contract of treasury bond futures rose to 0.62%, which continued to hit a new high. In addition, the 10-year main contract rose by 0.37%, the 5-year main contract rose by 0.27%, and the 2-year main contract rose by 0.09%, which was another record.

Many foreign ministers will hold talks in Jordan to discuss the latest development of the situation in Syria. Jordan announced that it will hold a meeting on December 14th local time to discuss the latest development of the situation in Syria. At the invitation of Jordan, the foreign ministers of the member countries of the Liaison Committee of Arab Ministers on Syria, established by the resolution of the Arab League, including Jordan, Saudi Arabia, Iraq, Lebanon and Egypt, and the Secretary-General of the Arab League, will hold a meeting in Aqaba, a city in southern Jordan. The meeting will also be attended by foreign ministers from the United Arab Emirates, Bahrain and Qatar. The Arab foreign ministers attending the meeting will also hold talks with the Turkish foreign minister, the US Secretary of State, the EU High Representative for Foreign Affairs and Security Policy, and the UN Special Envoy for Syria.Keshun Co., Ltd. and others set up a new building materials company in Jiangmen. The enterprise search APP shows that Jiangmen Yinzhou Lake Keshun Building Materials Co., Ltd. was established recently, with Feng Bihua as the legal representative and a registered capital of 1 million yuan. Its business scope includes: sales of photovoltaic equipment and components; Manufacturing of eco-environmental materials; Water pollution prevention and control services, etc. Enterprise investigation shows that the company is jointly held by Keshun and others.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.